Four Star Glass secures over 300 million yuan in funding, with Gao Tejia Investment leading the investment.

On April 27th, according to Gao Tejia Investment, recently, the leading domestic pharmaceutical neutral borosilicate glass company, Cangzhou Sisong Glass Co., Ltd., announced that it has received an additional financing of over 300 million yuan, bringing the total amount of funds raised in the short term to over 500 million yuan. This round of financing is led by Gao Tejia Investment, with specific contributions from Nanning Gao Tejia Fuyi Fund. The funds raised in this round will be used to advance the construction of the intelligent manufacturing base for the entire industry chain of Sisong Pharma in Nanning, Guangxi.